Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...
Study reveals regional differences in dementia drug use in nursing homes
Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...
Alzheimer's breakthrough as scientists discover drug that blasts memory robbing hotspots
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
Breakthrough Alzheimer’s drug successfully blocks both major disease ‘hotspots’ at once for the first time
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
earth13d
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
Neuroscience News2d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
psychiatryadvisor.com2d
Diabetes Drugs May Lower Risk for Types of Dementia Among Older Adults
The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
News Medical3d
Researchers make breakthrough in Alzheimer's disease drug development
The drug, a peptide inhibitor called RI-AG03, was effective at preventing the build-up of Tau proteins in both lab and fruit fly studies. The research, published in Alzheimer's & Dementia ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...